Cargando…

LKB1 pro‐oncogenic activity triggers cell survival in circulating tumor cells

During intravasation, circulating tumor cells (CTCs) detach from the epithelium of origin and begin the epithelial‐to‐mesenchymal transition (EMT) process, where they lose epithelial features and pass through the endothelium to enter circulation. Although detachment from the extracellular matrix is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trapp, Elisabeth Katharina, Majunke, Leonie, Zill, Beate, Sommer, Harald, Andergassen, Ulrich, Koch, Julian, Harbeck, Nadia, Mahner, Sven, Friedl, Thomas Wolfram Paul, Janni, Wolfgang, Rack, Brigitte, Alunni‐Fabbroni, Marianna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663996/ https://www.ncbi.nlm.nih.gov/pubmed/28700115 http://dx.doi.org/10.1002/1878-0261.12111

Ejemplares similares

Whole blood microRNAs as potential biomarkers in post-operative early breast cancer patients
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2018)

Estrogen Receptor and HER2 Status on Disseminated Tumor Cells and Primary Tumor in Patients with Early Breast Cancer
por: Jäger, Bernadette A.S., et al.
Publicado: (2015)

Evaluation of Two Different Analytical Methods for Circulating Tumor Cell Detection in Peripheral Blood of Patients with Primary Breast Cancer
por: Jaeger, B. A. S., et al.
Publicado: (2014)

Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer – Results of the German SUCCESS-A- trial
por: Jueckstock, Julia, et al.
Publicado: (2016)

Quantifying HER-2 expression on circulating tumor cells by ACCEPT
por: Zeune, Leonie, et al.
Publicado: (2017)

Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis—Results from the Adjuvant SUCCESS A Trial
por: Trapp, Elisabeth K., et al.
Publicado: (2022)

Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas
por: Schindlbeck, Christian, et al.
Publicado: (2005)

Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status
por: Vilsmaier, Theresa, et al.
Publicado: (2020)

Methylation patterns in serum DNA for early identification of disseminated breast cancer
por: Widschwendter, Martin, et al.
Publicado: (2017)

Rationale and description of a lifestyle intervention programme to achieve moderate weight loss in women with non-metastatic breast cancer: the lifestyle intervention part of the SUCCESS C Study
por: Hauner, Dagmar, et al.
Publicado: (2020)

Circulating Tumor Cells Predict Survival in Early Average-to-High Risk Breast Cancer Patients
por: Rack, Brigitte, et al.
Publicado: (2014)

Are Circulating Tumor Cells (CTCs) Ready for Clinical Use in Breast Cancer? An Overview of Completed and Ongoing Trials Using CTCs for Clinical Treatment Decisions
por: Schochter, Fabienne, et al.
Publicado: (2019)

SUMOylation regulates LKB1 localization and its oncogenic activity in liver cancer
por: Zubiete-Franco, Imanol, et al.
Publicado: (2018)

EpCAM(high) and EpCAM(low) circulating tumor cells in metastatic prostate and breast cancer patients
por: de Wit, Sanne, et al.
Publicado: (2018)

A high-throughput DNA methylation analysis of a single cell
por: Kantlehner, Martin, et al.
Publicado: (2011)

Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients
por: Zhang, Xi, et al.
Publicado: (2017)

The level of oncogenic Ras determines the malignant transformation of Lkb1 mutant tissue in vivo
por: Rackley, Briana, et al.
Publicado: (2021)

Angiogenic cytokines and their influence on circulating tumour cells in sera of patients with the primary diagnosis of breast cancer before treatment
por: Vilsmaier, Theresa, et al.
Publicado: (2016)

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2021)

The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial
por: Widschwendter, Peter, et al.
Publicado: (2015)

Randomised phase III trial of FEC120 vs EC-docetaxel in patients with high-risk node-positive primary breast cancer: final survival analysis of the ADEBAR study
por: Janni, W, et al.
Publicado: (2016)

The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer—a pooled analysis of the randomised clinical trials PlanB and SUCCESS C
por: de Gregorio, Amelie, et al.
Publicado: (2022)

Oncogenic miR-744 promotes prostate cancer growth through direct targeting of LKB1
por: Zhang, Minglei, et al.
Publicado: (2019)

Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses
por: Heitmeir, Benedikt, et al.
Publicado: (2022)

The Peutz-Jeghers kinase LKB1 suppresses polyp growth from intestinal cells of a proglucagon-expressing lineage in mice
por: Zac-Varghese, Sagen, et al.
Publicado: (2014)

Lkb1 maintains T(reg) cell lineage identity
por: Wu, Di, et al.
Publicado: (2017)

LKB1 tumor suppressor: Therapeutic opportunities knock when LKB1 is inactivated
por: Zhou, Wei, et al.
Publicado: (2014)

LKB1 is essential for the proliferation of T-cell progenitors and mature peripheral T cells
por: Tamás, Peter, et al.
Publicado: (2010)

Uncoupling of the LKB1-AMPKα Energy Sensor Pathway by Growth Factors and Oncogenic BRAF(V600E)
por: Esteve-Puig, Rosaura, et al.
Publicado: (2009)

Honokiol activates LKB1-miR-34a axis and antagonizes the oncogenic actions of leptin in breast cancer
por: Avtanski, Dimiter B., et al.
Publicado: (2015)

Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer—results from the randomized phase III SUCCESS-A trial
por: de Gregorio, Amelie, et al.
Publicado: (2020)

LKB1 suppression promotes cardiomyocyte regeneration via LKB1-AMPK-YAP axis
por: Qu, Shuang, et al.
Publicado: (2022)

Beyond LKB1 Mutations in Non-Small Cell Lung Cancer: Defining LKB1less Phenotype to Optimize Patient Selection and Treatment
por: Borzi, Cristina, et al.
Publicado: (2020)

Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells
por: Nakada, Daisuke, et al.
Publicado: (2010)

Control of T(reg) cell homeostasis and immune equilibrium by Lkb1 in dendritic cells
por: Chen, Song, et al.
Publicado: (2018)

Oncogenic Ras cooperates with knockdown of the tumor suppressor Lkb1 by RNAi to override organ size limits in Drosophila wing tissue
por: Rackley, Briana Brown, et al.
Publicado: (2020)

The HER2 phenotype of circulating tumor cells in HER2-positive early breast cancer: A translational research project of a prospective randomized phase III trial
por: Jaeger, B. A. S., et al.
Publicado: (2017)

LKB1 regulates quiescence and metabolic homeostasis of hematopoietic stem cells
por: Gan, Boyi, et al.
Publicado: (2010)

LKB1 and AMP-activated protein kinase: regulators of cell polarity
por: Nakano, Atsushi, et al.
Publicado: (2012)

LKB1 and AMPK differentially regulate pancreatic β-cell identity
por: Kone, Marina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2vv9ntv921d2tqi39g32v9pe59